29.11
Schlusskurs vom Vortag:
$28.56
Offen:
$28.06
24-Stunden-Volumen:
2.17M
Relative Volume:
0.86
Marktkapitalisierung:
$2.53B
Einnahmen:
$19.32M
Nettoeinkommen (Verlust:
$-141.47M
KGV:
-17.27
EPS:
-1.6851
Netto-Cashflow:
$-120.48M
1W Leistung:
+3.82%
1M Leistung:
+23.40%
6M Leistung:
+74.73%
1J Leistung:
+186.80%
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LQDA
Liquidia Corp
|
29.11 | 2.48B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
A Fresh Look at Liquidia (LQDA) Valuation Following Recent Share Price Surge - Yahoo Finance UK
Liquidia Corp's Chief Business Officer Sells Shares - TradingView
[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan
Meridian Wealth Management LLC Takes $168,000 Position in Liquidia Corporation $LQDA - MarketBeat
What sentiment indicators say about Liquidia Corporation stockJuly 2025 Trends & Safe Entry Zone Tips - newser.com
Why Liquidia Corporation (LT4) stock fits value portfolios2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
How Liquidia Corporation (LT4) stock reacts to new regulationsWall Street Watch & Technical Entry and Exit Alerts - newser.com
Will Liquidia Corporation (LT4) stock outperform small cap peersJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com
Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts. - Barron's
Liquidia (NASDAQ:LQDA) Hits New 52-Week HighHere's Why - MarketBeat
Liquidia Corporation $LQDA Stock Position Cut by Patient Square Capital LP - MarketBeat
Why Liquidia Corporation stock is a value investor pickJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Published on: 2025-11-19 05:01:37 - newser.com
Why Liquidia Corporation (LT4) stock is trending on social mediaEarnings Beat & Stock Portfolio Risk Control - newser.com
Can Liquidia Corporation (LT4) stock test all time highsJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Liquidia Technologies stock hits 52-week high of 29.97 USD By Investing.com - Investing.com South Africa
Liquidia Technologies stock hits 52-week high of 29.97 USD - Investing.com
Liquidia at Jefferies: Strategic Growth and Legal Challenges - Investing.com
Published on: 2025-11-18 05:06:23 - newser.com
Will Liquidia Corporation (LT4) stock beat value stocksTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-11-17 15:03:22 - newser.com
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - AOL.com
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Liquidia Corporation $LQDA - MarketBeat
Published on: 2025-11-17 12:10:02 - newser.com
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue - Finviz
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue - Insider Monkey
Mitsubishi UFJ Asset Management Co. Ltd. Sells 108,494 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Stock: Biotech Firm Delivers Stellar Performance - AD HOC NEWS
Chart overlay techniques for tracking Liquidia CorporationGDP Growth & Safe Capital Growth Plans - newser.com
How to escape a deep drawdown in Liquidia CorporationJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Tyro Capital Management LLC Takes $15.47 Million Position in Liquidia Corporation $LQDA - MarketBeat
Can Liquidia Corporation (LT4) stock sustain double digit ROEQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Liquidia Corp's Chief Accounting Officer Sells Shares - TradingView
Published on: 2025-11-12 09:23:46 - newser.com
Liquidia at UBS Global Healthcare: Strategic Growth in Focus - Investing.com
Will Liquidia Corporation stock benefit from automation2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Liquidia Shares Surge on Exceptional Quarterly Performance - AD HOC NEWS
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):